Skip to navigation Skip to main content

PURIXAN® (mercaptopurine [6-MP] oral suspension)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for PURIXAN® (mercaptopurine [6-MP] oral suspension), indicated for acute lymphoblastic leukemia.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 10: Clinical Pharmacology
Slide 14: Warnings and Precautions
Slide 18: Clinical Safety and Efficacy
Slide 21: Drug Storage and Supply

Topics:

Acute Lymphoblastic Leukemia Drug Showcase Hematologic Cancers
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides